Helius Medical Technologies, Inc. (HSDT): Kapitalisasi marang pendapatan
The price-to-sales multiple helps determine the boundaries of business value, with the current figure standing at 7.30. Transparent commercialization of the neuroplatform and management's expertise in handling insurance reimbursements minimize risks. An eco-friendly approach to creating energy-efficient stimulation systems reduces environmental impact. Helius Medical (HSDT) is currently scaling the deployment of PoNS devices by expanding its clinic network and training US specialists.
Rincian analitis perusahaan Helius Medical (HSDT)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Helius Medical|HSDT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas heliusmedical.com|HSDT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Helius Medical Technologies Inc.|HSDT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Helius Medical Technologies|Rasio jangkoan perantara heliusmedical.com
- data bathi lan kelipatan valuasi:
HSDT - Bathi resik perusahaan|Prakiraan bathi perusahaan Helius Medical|HSDT - Pangali P/E|Rasio rega marang bathi mangsa ngarep heliusmedical.com|HSDT - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Helius Medical Technologies Inc.|HSDT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Helius Medical Technologies|HSDT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan heliusmedical.com|HSDT - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Helius Medical
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:HSDT Helius Medical Technologies, Inc.
To assess the investment attractiveness of Helius Medical (HSDT), it is essential to compare the business's market value with its actual revenue. By analyzing the company's historical P/S ratio on GURU.Markets, an investor determines how many dollars of market capitalization are attributed to one dollar of sales. This multiple is critical for Helius Medical (HSDT), as outsourcing production and support reduces capital expenditures. A rise in share prices without a proportional increase in revenue signals that the asset is overvalued.
Pesaing Helius Medical
BIIB (biogen.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Neurocrine Biosciences, Inc. NBIX|RGC - Kapitalisasi marang pendapatan|Axsome Therapeutics Inc - Multiplikator P/S|Rega marang dodolan ACADIA Corp|XENE: Multiplikator P/S|Rasio kapitalisasi marang pendapatan VKTX|SUPN (Supernus) - Multiplikator P/S|Catalyst Pharma (CPRX) - Koefisien rega marang pendapatan|Multiplikator P/S DNLI|Kapitalisasi marang pendapatan Harmony Corp HRMY|Multiplikator P/S BHVN (Biohaven Ltd.)|Multiplikator P/S amylyx.com AMLX|TRVI - Rasio rega marang pendapatan|PRAX: Rasio rega marang pendapatan|AVXL: Multiplikator P/S|CeriBell EEG - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Prothena Biosciences|Alector Therapeutics (ALEC) - Koefisien rega marang pendapatan|Multiplikator P/S ANNX|omeros.com - Rasio kapitalisasi marang pendapatan|Neurogene Corp - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ACIU (AC Immune Inc)|VYGR - Rasio rega marang pendapatan|NMRA (neumoratx.com) - Rasio kapitalisasi marang pendapatan|SCLX: Multiplikator P/S|Rega marang dodolan Tevogen Bio Holdings Inc. (TVGN)|Kapitalisasi marang pendapatan ACOG|Multiplikator P/S Cognition Therapeutics Inc.|Rasio rega marang pendapatan Inhibikase Therapeutics (IKT)|SAVA (cassavasciences.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Assertio ASRT|Coya Therapeutics Inc (COYA) - Rega marang dodolan|VistaGen Therapeutics Inc - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan OVID (Ovid Therapeutics Inc.)|ABOS: Multiplikator P/S|Rega marang dodolan cervomed.com (CRVO)|Rasio rega marang pendapatan Alterity Therapeutics Ltd.|Rasio rega marang pendapatan CLNN|Multiplikator P/S PEPG|Koefisien rega marang pendapatan Jupiter Neurosciences, Inc.|Relmada Therapeutics - Kapitalisasi marang pendapatan|Multiplikator P/S annovisbio.com ANVS|GRCE - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Firefly Neuroscience, Inc. AIFF|KLTO (anewmeds.com) - Kapitalisasi marang pendapatan|NeuroSense Therapeutics Ltd. - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Reviva Pharmaceuticals|Kapitalisasi marang pendapatan MetaVia, Inc. (MTVA)|Multiplikator P/S NRXS|PASG - Rega marang dodolan|Multiplikator P/S NEUP (Neuphoria Therapeutics)|NERV: Rasio kapitalisasi marang pendapatan|Athira Pharma, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan addextherapeutics.com ADXN|ALZN: Multiplikator P/S|Kapitalisasi marang pendapatan Cyclerion Therapeutics, Inc.|PTIX (Protagenic Therapeutics Inc.) - Multiplikator P/S|Multiplikator P/S Pasithea|Rasio rega marang pendapatan Cortigent, Inc. (CRGT)|Rasio rega marang pendapatan ATXI (avenuetx.com)|Multiplikator P/S BCLI (BrainStorm Cell Therapeutics)|Rasio kapitalisasi pasar marang pendapatan CARA|CHRO - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Eliem Therapeutics ELYM|ITCI: Multiplikator P/S|Rasio kapitalisasi marang pendapatan LBPH|Kapitalisasi marang pendapatan MRNS|NKGN (NKGen Biotech Inc) - Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan NeuroBo (NRBO)|Sage Therapeutics Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S SNPX (Synaptogenix, Inc.)|trevena.com (TRVN) - Rega marang dodolan|VIGL: Kapitalisasi marang pendapatan|WENA - Multiplikator P/S|Cerevel (CERE) - Rasio rega marang pendapatan
